Two such entities emerge from the chaos: Tractor Supply (TSCO), custodian of rural America’s quiet resilience, and Kroger (KR), steward of the grocery cart’s sacred duty. One sells the tools of subsistence; the other, the sustenance itself. Together, they form a diadem of dependability in a world where even the moon might forget to rise.
Until now, the pharmaceutical industry had grown accustomed to the rhythm of regulatory approval and clinical trials, where risks were measured and tangible. But the true peril of recent times has come not from the science of medicine, but from the hand of politics. With President Trump’s public vow to lower drug prices and his threats to impose tariffs on pharmaceutical imports, companies like Pfizer faced an uncertain future, their earnings threatened by forces far beyond their control. The political winds had shifted, and there was an undeniable sense of unease in the markets.
To claim the Shiller P/E is a perfect predictor would be to mistake a compass for a map. Yet its track record is troubling. Since 1871, the ratio has exceeded 30 on six occasions. Each was followed by a collapse of 20% or more. The first, in 1929, preceded the Great Depression. The second, in 1999, heralded the dot-com implosion. The third, in 2018, foreshadowed a 20% plunge. The fourth, in 2020, coincided with the pandemic crash. The fifth, in 2022, marked the start of a bear market. And the sixth? It is ongoing, with the ratio now at 40.15.
These are not mere numbers; they are the ghosts of past excesses, whispering warnings in the ears of the present. The Shiller P/E is not a crystal ball, but a rearview mirror. And what it reflects is a pattern as old as capitalism itself: greed, followed by fear, followed by a reckoning.
Consider the “next-big-thing” trends of the past three decades. The internet, blockchain, AI-each has been hailed as a revolution, only to be met with the same cycle of hype and disillusionment. Investors, like children at a candy store, have consistently overestimated the utility of these innovations. AI, for all its promise, remains a box of chocolates: you never know what you’re gonna get.
Loading…
–
Though we’ve lived in this “new normal” since the 1990s, there is little question that stocks are now priced with the optimism of a man who’s just sold his car for a goat. History, that relentless pedant, reminds us that anchoring to such valuations is a fool’s errand. The market is not a machine; it is a theater of human folly, where the final act is always the same: the curtain falls, the lights dim, and the audience is left to count the coins in their pockets.
And yet, the performance continues. The music plays on.
The AI boom, that most fashionable of trends, has been a veritable feast for CoreWeave’s coffers. In its second quarter, the company’s revenue leapt with the enthusiasm of a springer spaniel at a fox hunt-206%, to be precise, landing a tidy $1.21 billion. Such figures, one must confess, make one’s head spin like a top at a children’s party.
This stock love fest was courtesy of Northcoast Research, where analyst Keith Housum rolled out the red carpet for Symbotic, recommending a price target of $65 per share. Because nothing says “I believe in you” quite like a nice dollar amount with a fancy label.
This sad spectacle stems from a horde of news outlets and analysts, who have taken to scolding MercadoLibre as Amazon, that gargantuan, gluttonous ogre, prepares to unleash its most fiendish scheme yet upon Brazil-the land where MercadoLibre’s heart beats strongest.
The crypto world is a broken clock that occasionally tells the right time-and Bitcoin, that grizzled old outlaw, just struck a match. Up nearly 10% this week, Bitcoin’s rally is less about fundamentals and more about the U.S. government’s latest stunt, a shutdown that’s turned investors into paranoid gamblers. “Digital gold,” my ass-it’s more like digital nitroglycerin. And Dogecoin? That’s the sparkler strapped to your ankle.
Picture this: market open, 8:30 AM, coffee in hand, when BAM-Canaan drops a press release thicker than a Silicon Valley IPO pitch deck. Some mystery client (who shall remain nameless, like a crypto Batman) ordered 50,000 Avalon A15 Pro miners. That’s not just a big deal-it’s the largest order since the Obama administration’s “Yes We Canaan” campaign failed to launch.
It was after the market’s customary hour of repose that Bullish revealed its hand, declaring an intention to introduce crypto options upon its platform. This venture, set to unfold on Wednesday, Oct. 8, shall be undertaken with the aid of several esteemed companions in the financial world-Abraxas Capital Management, Flow Traders, and FalconX among them. The service, though aimed at the more discerning palate of institutional investors, promises to elevate the conversation from mere speculation to a more refined engagement with risk and reward.
The quantum realm, a domain of boundless promise yet perilous ambiguity, witnessed a flicker of validation as Rigetti Computing’s sale of two Novera systems ignited a spark. The $5.7 million in orders, a drop in the ocean of corporate ambition, yet to Rigetti, it was a beacon. But what of the broader market? Does such a transaction, a mere whisper in the grand design, herald a dawn or merely a fleeting illusion? D-Wave, ever the specter of possibility, rode this wave, its stock a mirror to the collective psyche’s hunger for salvation.